ASX ANNOUNCEMENT Argenica Therapeutics Limited (ACN 637 578 753) ¦ASX: AGN 4/117 Broadway, Nedlands WA 6009 ¦+618 9329 3396 www.argenica.com.au DATE OF AGM AND CLOSING DATE FOR DIRECTOR NOMINATIONS Perth, Australia; 23 September 2026 – Argenica Therapeutics Limited (Argenica or Company)...
AGM Date & Closing Date for Director Nominations
Filed with ASX ·
6ix hasn’t read this filing yet.
Argenica Therapeutics Ltd on 6ix
Earlier from Argenica Therapeutics
- Concussion Data Selected for Neurotrauma Congress
- Appendix 4E & Annual Report to 30 June 2026
- Appendix 4G & Corporate Governance Statement
- Notification of cessation of securities - AGN
- ARG007 Shows Significant Neuroprotection in Concussion Study
Later from Argenica Therapeutics
- Change of Director's Interest Notice
- Notice of Annual General Meeting/Proxy Form
- New Mechanism Findings Offer Insights Into Phase 2 Signal
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Argenica Therapeutics into a list and get an email when it puts out news.
Follow Argenica Therapeutics